This review summarizes updated information on the role of the CCL5/CCR5 axis in tumor development and/or progression, focusing primarily on multiple myeloma (MM), classical Hodgkin lymphoma (cHL), prostate, breast, gastric, colon, and ovarian cancer, and melanoma. This evidence concerns the gene CCL5 and melanoma.